Cavitation-Biodiesel

CRWEFinance.com Hot Stock News & Alerts!

________________________________________

FREE Daily Stock Alerts From CRWEFinance.com

________________________________________

CRWEFinance.com Stock Report!

********************************************************************************

Cellceutix Corporation (OTCBB:CTIX), a bio-pharmaceutical company that develops small molecules to treat cancer and inflammatory disease, today announced that is has concluded an agreement with Toxikon Corporation of Bedford, Massachusetts, to conduct the remaining preclinical studies required for an Investigational New Drug (IND) filing for its cancer drug Kevetrin(TM). The terms of the agreement were not disclosed. The studies covered by the agreement are designed to confirm that Kevetrin meets FDA safety requirements for studies in humans.

POWERSAFE TECHNOLOGY (PSFT.PK) Subsidiary; Amplification Technologies has patented a revolutionary solution for low-level signal detection: multichannel Discrete Amplification (DA).

***********Advertisement***********

********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received five thousand dollars from a third party for 30 days of advertisement services for PowerSafe Technology Corp. (PSFT.PK).

Tags: Amplification, bio-pharmaceutical, cancer, CTIX, DA, fda, humans, IND, inflammatory disease, Kevetrin, low-level signal detection, molecules, preclinical studies, PSFT, TM, Toxikon Corporation of Bedford

This entry was posted on Monday, November 2nd, 2009 at 11:26 am and is filed under Business News. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.